GSA Capital Partners’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
+88,195
| New | +$1.31M | 0.09% | 306 |
|
|
2025
Q1 | – | Sell |
-74,356
| Closed | -$1.3M | – | 2087 |
|
|
2024
Q4 | $1.3M | Buy |
+74,356
| New | +$1.3M | 0.1% | 250 |
|
|
2024
Q2 | – | Sell |
-58,601
| Closed | -$452K | – | 2033 |
|
|
2024
Q1 | $452K | Buy |
+58,601
| New | +$452K | 0.04% | 948 |
|
|
2021
Q1 | – | Sell |
-41,806
| Closed | -$1.14M | – | 1503 |
|
|
2020
Q4 | $1.14M | Buy |
+41,806
| New | +$1.14M | 0.19% | 100 |
|
|
2018
Q4 | – | Sell |
-11,600
| Closed | -$333K | – | 1741 |
|
|
2018
Q3 | $333K | Buy |
+11,600
| New | +$333K | 0.02% | 1273 |
|
|
2018
Q1 | – | Sell |
-28,100
| Closed | -$592K | – | 1834 |
|
|
2017
Q4 | $592K | Buy |
28,100
+16,400
| +140% | +$346K | 0.04% | 857 |
|
|
2017
Q3 | $291K | Sell |
11,700
-2,700
| -19% | -$67.2K | 0.02% | 1274 |
|
|
2017
Q2 | $279K | Buy |
+14,400
| New | +$279K | 0.02% | 1323 |
|
|
2017
Q1 | – | Sell |
-33,245
| Closed | -$629K | – | 1999 |
|
|
2016
Q4 | $629K | Buy |
33,245
+14,345
| +76% | +$271K | 0.04% | 847 |
|
|
2016
Q3 | $423K | Sell |
18,900
-27,609
| -59% | -$618K | 0.02% | 1152 |
|
|
2016
Q2 | $828K | Buy |
46,509
+18,920
| +69% | +$337K | 0.05% | 753 |
|
|
2016
Q1 | $377K | Buy |
+27,589
| New | +$377K | 0.02% | 1176 |
|
|
2015
Q4 | – | Sell |
-48,990
| Closed | -$993K | – | 1971 |
|
|
2015
Q3 | $993K | Buy |
48,990
+39,470
| +415% | +$800K | 0.05% | 635 |
|
|
2015
Q2 | $316K | Buy |
+9,520
| New | +$316K | 0.01% | 1590 |
|
|
2014
Q4 | – | Sell |
-30,444
| Closed | -$275K | – | 1902 |
|
|
2014
Q3 | $275K | Buy |
+30,444
| New | +$275K | 0.01% | 1318 |
|